Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07189234 · ClinicalTrials.gov registry record · Phase 2
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
A Phase 2 study of PreDiabetes and Metabolic Syndrome, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT07189234: Recruiting Phase 2 study of PreDiabetes and Metabolic Syndrome, sponsored by University of California, San Diego.
NCT07189234 is a Phase 2 study of PreDiabetes and Metabolic Syndrome that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 140 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07189234, a Phase 2 study of PreDiabetes and Metabolic Syndrome, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
In a randomized controlled trial, the investigators intend to measure the health impact of time restricted eating (TRE) in patients with metabolic syndrome (with elevated blood pressure and at least 2 of the following: increased waist circumference, abnormal cholesterol levels, elevated triglycerides, and elevated fasting glucose levels), who habitually eat more than 12 hours every day. Patients will be randomly assigned to a control group (standard of care) or intervention group (TRE).
Primary Outcome
Assessed via HbA1c (%)
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Time-restricted eating (TRE) + Standard of Care
Study Locations (1)
California
- Altman Clinical and Translational Research Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2029-01-06 |
| Phase | Phase 2 |
What NCT07189234 shows while recruiting
NCT07189234 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT07189234 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07189234 about?
NCT07189234 is a clinical study titled "Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health". In a randomized controlled trial, the investigators intend to measure the health impact of time restricted eating (TRE) in patients with metabolic syndrome (with elevated blood pressure and at least 2 of the following: increased waist circumference, abnormal cholesterol levels, elevated triglyceride...
What is the current status of trial NCT07189234?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2025-10-23. Estimated completion is 2029-01-06.
What conditions does trial NCT07189234 study?
This clinical trial studies the following conditions: PreDiabetes, Metabolic Syndrome.
What interventions are being tested in trial NCT07189234?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Time-restricted eating (TRE) + Standard of Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07189234?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07189234 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07189234's enrollment target sits among peer trials
140 53rd of 149 higher than 97 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
RECRUITING · Phase 2
-
Mechanisms for Activation of Beige Adipose Tissue in Humans
RECRUITING · Phase 2
-
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
RECRUITING · Phase 2
-
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI